Found 8 matching trials
A Study for Patients Who Completed VITALITY-ALS (CY 4031)
PHASE3The purpose of this study is to assess the long-term safety and tolerabilit...
Location
St. Joseph's Hospital and Medical Center - Barrow Neurology Clinics
Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices After Treatment for a Year
PHASE3This study assessed the effect of tirasemtiv versus placebo on respiratory ...
Location
St. Joseph's Hospital & Medical Center - Barrow Neurology Clinics
Pharmacodynamic Study of CK-2017357 in Patients With Generalized Myasthenia Gravis
PHASE2The primary objective of this early-stage clinical study is to demonstrate ...
A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
PHASE2The primary objective of this study is to demonstrate a pharmacodynamic eff...
Location
Phoenix Neurological Associates, Ltd.
A Study to Evaluate the Effects of Multiple Doses of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
PHASE2The study will generate data on safety, tolerability and pharmacokinetics a...
Location
California Pacific Medical Center
Study of Safety, Tolerability & Efficacy of CK-2017357 in Amyotrophic Lateral Sclerosis (ALS)
PHASE2The purpose of this research study is to evaluate the safety and effectiven...
Dose Titration Study to Test Safety and Effects of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
PHASE2A Phase II, double-blind, randomized, placebo-controlled ascending dose tit...
Location
University of California at San Francisco, Fresno Campus, Central California Neurological Institute
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
PHASE2The primary objective of this early-stage clinical study is to demonstrate ...
Location
Tatum Ridge Internal Medicine